echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Lost for 4 consecutive years!

    Lost for 4 consecutive years!

    • Last Update: 2021-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


















    Not long ago, there were rumors that Hutchison Medicine would conduct an IPO of US$500 million in Hong Kong stocks as early as the first half of this year.
    In response, Hutchison Medicine responded that there are no plans for the time being, but it will continue to monitor market conditions
    .
    If related IPOs are launched in the future, cornerstone investors will be introduced
    .


    However, He Jun, CEO of Hutchison Pharmaceuticals, once stated at the company's performance meeting for the first half of 2020 that he hopes to sign an amendment to the sales rights of Fruquintinib with Eli Lilly and achieve the commercialization of Sofatinib after its listing.
    After that, choose an opportunity to list in Hong Kong
    .
    In this view, it is only a matter of time before Hutchison Medicine goes public in Hong Kong
    .


    Reference materials:


    The Paper: Hutchison Pharma responds to restarting Hong Kong stock IPOs: still discussing, science and technology innovation board is also considering scope


    International Finance News: Hutchison Pharma achieves revenue of US$228 million in 2020, and Syvotinib is approved in the second quarter of this year

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.